Charles River guides FY2026 to upper end of range, sets 2030 targets at investor day; shares rise

SentiSense · Published · Updated

At its Sept. 24 Investor Day, Charles River Laboratories (CRL) said it now expects FY2026 revenue and non-GAAP EPS at the upper end of its guidance ra...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis